Will cancellation criteria of innovative pharmaceutical firms be discussed in upcoming parliamentary

Published: 2012-10-12 06:59:00

Updated: 2012-10-12 06:59:00

All eyes are on the upcoming parliamentary interpellation session on October 24, during which the cancellation criteria of innovative pharmaceutical firms is likely to be a hot issue.

Investigators raided the headquarters of the nation’s leading pharmaceutical company Wednesday to probe an all...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK